Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-08
2010-11-02
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S363000
Reexamination Certificate
active
07825125
ABSTRACT:
Morphologically stabilized amorphous aripiprazole and process for preparing the same.
REFERENCES:
patent: 4734416 (1988-03-01), Banno et al.
patent: 5006528 (1991-04-01), Oshiro et al.
patent: 2004/0170672 (2004-09-01), Selzer
patent: 2004/0247870 (2004-12-01), Brown et al.
patent: 2005/0245539 (2005-11-01), Mendla et al.
patent: 2005/0272742 (2005-12-01), Worthen et al.
patent: 2008/0020038 (2008-01-01), Stritzke et al.
patent: 2008/0280921 (2008-11-01), Dreyer et al.
patent: 1398040 (2004-03-01), None
patent: 1 419 776 (2004-05-01), None
patent: 1 330 249 (2006-04-01), None
patent: WO 03/026659 (2003-04-01), None
patent: WO 2004/083183 (2004-09-01), None
patent: WO 2004/106322 (2004-12-01), None
patent: WO 2005/009990 (2005-02-01), None
patent: WO 2005/016262 (2005-02-01), None
patent: WO 2005/058835 (2005-06-01), None
patent: WO 2006/053781 (2006-05-01), None
patent: WO 2006/079549 (2006-08-01), None
patent: WO 2007/073389 (2007-06-01), None
patent: WO 2008/020820 (2008-02-01), None
Aoki et al., “Study on Crystal Transformation of ARIPIPRAZOL,” The Proceedings of the 4thJapanese-Korea Symposium on Separation Technology, CR.119 (Oct. 6-8, 1990 pp. 937-940.
www.fda.gov/cder/foi
da/2002/21-436, Abilify—biophamr—P2.
FDA, Enforcement Report, Aug. 25, 2004 and Jul. 6, 2005.
Office Action issued Jan. 25, 2010 in U.S. Appl. No. 12/131,618.
Glänzer Klaus
Löffler Uwe
Stritzke Katja
Helm AG
Sackey Ebenezer
Swanson & Bratschun L.L.C.
Wilson James O
LandOfFree
Amorphous aripiprazole and process for the preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amorphous aripiprazole and process for the preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amorphous aripiprazole and process for the preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4194418